Impella CP®

with SmartAssist® Heart Pump
Percutaneous insertion, increased flow and intelligent patient management


The Impella CP® with SmartAssist Heart Pump® marks a significant advancement in circulatory support technology, offering an innovative solution for patients with severe cardiac conditions. 

This next-generation intravascular microaxial blood pump uses real-time intelligence to optimize patient outcomes and enhances the positioning, management, and weaning of the device. Optimally positioned via a percutaneous insertion through the femoral artery or surgically through the axillary artery, the Impella CP with SmartAssist delivers critical support directly to the left ventricle, reducing cardiac workload and improving systemic perfusion with a peak flow of up to 4.3 L/min. Designed for high-risk percutaneous coronary interventions (PCI) and post-acute myocardial infarction cardiogenic shock (AMI CS), the device supports the circulatory system for up to five days.

Product Specifications

  • Cannula: Polyurethane coated nitinol with a 145-degree angle

  • Easy Guide Lumen: Red loading lumen to ease guidewire loading

  • Catheter Shaft: Polyurethane catheter with nitinol backbone and triple internal lumens for pressure, purge and electrical signal

  • Position Sensor: Optical pressure sensor located immediately distal to the outlet, provides a pressure reading indicating aortic pressure only when both the outlet and sensor are located within the aorta

  • Repositioning Unit: Graduated shaft from 9 Fr to 13 Fr with StatLock®* compatible suture pads and anti-contamination sleeve. Guidewire reaccess sheath maintains guidewire access to arteriotomy. 13 Fr section is 10cm in length

  • Red Impella Plug: Connections - 1 luer connection for purge fluid, 1 electrical connection direct to Automated Impella® Controller


Axillary Insertion with Impella CP with SmartAssist

Explore the step-by-step Axillary Insertion process of the state-of-the-art Impella CP with SmartAssist Heart Pump through the axillary artery and into the left ventricle. This advanced intravascular blood pump is designed to support patients undergoing high-risk percutaneous coronary interventions and those suffering from cardiogenic shock

Comprehensive Overview of Clinical Evidence and the SmartAssist Platform


Additional Resources

Learn more about the SmartAssist platform, new features, the Automated Impella® Controller and specifications.


Download the comprehensive datasheet now to explore all the features and benefits


Access the Full Step-by-Step Guide for the Impella CP with SmartAssist Heart Pump


Accessories and Ordering Information

CP SmartAssist In-Package kit
Automated Impella® Controller
Introducer Kit
Purge Cassette

Indication and Safety Information EU


The Impella CP with SmartAssist® (intracardiac pump for supporting the left ventricle) is intended for clinical use in cardiology and in cardiac surgery for up to 5 days for the following indications, as well as others:
· The Impella is a circulatory support system for patients with reduced left ventricular function, e.g., post-cardiotomy, low output syndrome, cardiogenic shock after acute myocardial infarction, or for myocardial protection after acute myocardial infarction
· The Impella may also be used as a cardiovascular support system during coronary bypass surgery on the beating heart, particularly in patients with limited preoperative ejection fraction with a high risk of postoperative
low output syndrome.
· Support during high risk percutaneous coronary intervention (PCI)
· Post PCI


· Mechanical aortic valves, severe aortic valvular stenosis or valvular regurgitation
· Hematological disorder causing fragility of the blood cells or hemolysis
· Hypertrophic obstructive cardiomyopathy (HOCM)
· Aneurysm or necrotomy or severe anomaly of the ascending aorta and / or the aortic arch
· Mural thrombus in the left ventricle
· Ventricular septal defect (VSD) after myocardial infarction
· Anatomic conditions precluding insertion of the pump
· Other illnesses or therapy requirements precluding use of the pump
· Severe peripheral arterial occlusion disease (PAOD) is a relative contraindication


There are risks of complications with every procedure using a blood pump. These include among others:
Dazu gehören u. a.:
· Hemolysis
· Bleeding
· Immune reaction
· Embolism, thrombosis
· Vascular injury through to angionecrotomy
· Positioning problems
· Infection and septicemia
· Dislocation of the pump
· Cardiovalvular injuries due to extreme movement of the suction cannula in relation to the cardiac valve or
as a result of attachment by suction of the pump to the valve system following incorrect positioning
· Endocardiac injuries as a result of attachment of the pump due to suction
· Pump failure, loss of pump components following a defect
· Patient dependency on the pump after use for support
In addition to the risks above, there are other WARNINGS and PRECAUTIONS associated with Impella devices.
For more information please see the Instructions for Use Manuals.


*StatLock is a trademark of Becton, Dickinson and Company

**Only for use in ventricular pumps

1. Fincke 2004 J Am Coll Cardiol_CGS SHOCK registry (v2.0)


This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].